In this report a fast and robust chip-based capillary electrophoresis (CE) method is described, determining lithium ions in blood samples. The blood plasma was generated with a separate on-chip plasma filtration module. In preceding experiments with the CE system, the detection limit of lithium analyzed on its own was shown to be 50 μmol•L -1 . Due to the challenging sample matrix, a lithium calibration directly within the blood plasma was performed. A clear separation of lithium and sodium ions could be carried out with a MES/His background electrolyte at a separation voltage of 3.8 kV. The limit of detection for lithium in blood plasma was verified to be less than 250 µmol•L -1 , assuring a reliable quantification. Combined with the on-chip plasma generation, the time from withdrawing the blood sample to the analysis result was reduced to less than 5 minutes.
Introduction
Over the last years, chip-based analytical methods, especially chip-based CE has proven its advantages as an analytical method in a large number of applications, namely the improved speed and the overall simplification in handling of the analytical process [1] . In addition, the miniaturization of the separation column can lead the way to the miniaturization of the complete analytical instrument, paving the road towards a portable analytical system which can be used at the sample site instead of transferring the sample to the instrument site. Therefore, several concepts of portable instruments have been discussed in the past, mainly in the field of point-of-care diagnostics [2] .
An ideal example for the application of the miniaturized CE-system "ChipGenie ® edition E" is the medical monitoring of blood parameters, for instance the determination of lithium in blood serum. Lithium therapy is a common treatment for bipolar mood disorders. The therapeutic range of lithium in blood serum reaches from 0.5 mmol•L -1 to 1.2 mmol•L -1 . The problematic aspect of this therapy is that toxic effects start to appear close to the therapeutic range at a lithium concentration of approximately 1.6 mmol•L -1 [3, 4] . Due to the 100-fold excess of sodium ions compared to lithium ions in blood plasma, the determination of lithium in this matrix is challenging.
Conventionally, plasma lithium concentrations are determined with ion-selective electrodes [5] . In this paper we will present a complete chip-based capillary electrophoresis system using capacitively coupled contactless conductivity detection (C 4 D).
Methods
The small and portable capillary electrophoresis system "ChipGenie ® edition E" was used in the experiments. In combination with a disposable microfluidic CE-chip the electrophoresis device presents a simple to use system, ideally suited for on-site biomedical analysis. The blood plasma was generated from anticoagulated whole blood samples using an additional on-chip plasma generation module.
2.1
Electrophoresis system "ChipGenie ® edition E" "ChipGenie ® edition E" is a microfluidic based analysis system for the separation of charged analytes using capillary electrophoresis with contactless capacitively coupled conductivity detection. The system consists of a microfluidic disposable and the instrument ( Fig. 1 ) with high voltage power supply and detection electronics. The instrument is connected to a computer via an USBinterface which enables the complete power supply, the system control and the data readout of the "ChipGenie ® edition E"-system. A bipolar high voltage generator transforms the 5 V USB power up to ±3.8 kV without the need of a further external power supply.
The microfluidic chip is made of plastics like poly(methyl methacrylate) (PMMA) or cycloolefine polymers (COP) by injection molding. It consists of a fluidic channel system with sample injection and separation channels, featuring a cross section of 50 µm x 50 µm. The intersection of both channels, the injection cross, defines the sample volume of approx. 50 fL, which will be injected to the separation channel. The length of the separation channel is 75 mm. The reservoirs for buffer and sample (Fig. 2 , left: R1-R4) are integrated on the chip. Featuring a nominal volume of 70 µL, they have the shape of female press-fit Luer fittings. Thereby the reservoirs are matching to a large variety of commercially available sources for liquid handling, e.g. disposable syringes. The channels of the chip are covered with a 60 µm thin foil, which enables optimized performance. The electrodes for detection consist of a thin layer of platinum and gold. They are applied on the outer bottom side of the separation channel. This C 4 D-detection method avoids the electrodes from fouling (Fig. 2, right) . 
Reagents
The background electrolyte (BGE) for the measurements was consisting of 50 mmol•L 
Blood samples
The blood samples were obtained from healthy volunteers and stabilized with EDTA. The plasma was generated with a separate on-chip plasma filtration module (Fig. 3) . This membrane chip allows separating blood plasma from 20 µL to 40 µL of stabilized whole blood per membrane within less than 2 minutes. The yield is between 75 % and 85 % of plasma. For each analysis 60 µL plasma was generated, requiring approx.120 µL whole blood and one plasma generation chip with 4 parallel filtration membranes. The plasma filtration was handled manually using a laboratory pipette ( 
Measurement routine
The chip was filled with the MES/His BGE and inserted to the "ChipGenie ® edition E" instrument. To ensure equal conditions concerning to the temperature, five measurements without sample were performed initially before each sample run. Then the BGE was removed from the sample reservoir and replaced by the sample. The measurement itself was repeated for five times to take an average. The instrument was set to the following parameters for all measurements: separation voltage +3.8 kV; injection voltage 0.5 kV; separation time 120 s; injection time 5 s.
Results
First, a calibration with external lithium standards was carried out. Lithium ions were detected between 31 s and 37 s with standard deviations between ±0.8 % and ±3.2 % for five repetitions. The peak areas were used to generate a calibration curve. The curve (Fig. 4) shows a linear progression. The standard deviations are between ±16.1 % and ±21.3 %, showing the necessity of performing at least five repetitions for each analysis. The limit of detection is resulting from the noise of the background signals in the electropherograms. It was verified to be at a peak height of 0.31 mV, resulting in a concentration for lithium of less than 50 µmol•L -1 .
Figure 4
Calibration curve for lithium in buffer with linear regression, average from 5 measurements each
Due to the 100-fold excess of sodium compared to lithium ions in blood plasma, the determination of lithium in this matrix is challenging. For that a calibration in the analyte matrix was carried out (Figs. 5 and 6 ). The freshly generated plasma was spiked with a lithium standard solution. Volumetric errors could be neglected using a comparatively high lithium concentration of 144 mmol•L -1 .
Lithium was detected between 46 s and 50 s with standard derivations between ±0.5 % and ±4.2 % for five repetitions. Based on the noise of the background signal the limit of detection for lithium in blood plasma matrix was verified to be less than 250 µmol•L 
Conclusion
We have presented a complete chip-based capillary electrophoresis system based on the principle of capacitively coupled contactless conductivity detection. Its main features are the compact and portable instrument containing all the high-voltage and high frequency electronics and the disposable injection molded plastic chip, containing the fluidic reservoirs as well as the detection electrodes.
The determination of lithium in blood with miniaturized on-chip CE is a fast, robust, and economic alternative to conventional lab analysis. A clear separation of lithium and sodium ions could be carried out with a BGE consisting of 50 mmol•L -1 MES and 50 mmol•L -1 His at a separation voltage of 3.8 kV. The limit of detection for lithium in blood plasma was verified to be less than 250 µmol•L -1 , assuring a reliable quantification within the therapeutic range. Only 120 µL blood sample is necessary for the whole measurement. Combined with the on-chip plasma generation, the time from withdrawing the blood sample to the analysis result was decreased to less than 5 minutes.
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